Efficacy of Rituximab in Refractory Inflammatory Myopathy Associated With Coexistence of Behçet's Disease and Antiphospholipid Syndrome
A 43-year-old Caucasian male initiated myalgias and loss of muscle strength in the upper and lower limbs, but especially at the shoulder and pelvic girdle. Creatinine phosphokinase was elevated seven-fold above the normal reference value and aldolase was slightly elevated. He had a previous diagnosi...
Main Authors: | Verónica Guiomar, Diana Oliveira, Cristina Correia, Edite Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2019-11-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/1294 |
Similar Items
-
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
by: Fernando Henrique Carlos de Souza, et al.
Published: (2018-09-01) -
Experience of polymyositis and antisynthetase syndrome treatment with rituximab
by: S. G. Palshina, et al.
Published: (2015-02-01) -
The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature
by: S. Barsotti, et al.
Published: (2018-07-01) -
Idiopathic inflammatory myopathies: Contributions from India
by: Anand Narayan Malaviya
Published: (2020-01-01) -
Diagnostic criteria for idiopathic inflammatory myopathies. Problems of their optimization
by: O. A. Antelava, et al.
Published: (2014-09-01)